For the ARCHITECT Toxo IgM assay, an increase in grayzone and/or false reactive results have been observed for samples from immunocompromised patients or newborns as well as cord blood samples for the lot numbers enclosed. These sample types share the commonality of low total immunoglobulin M (IgM) titer.